JP2018065821A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018065821A5 JP2018065821A5 JP2017218514A JP2017218514A JP2018065821A5 JP 2018065821 A5 JP2018065821 A5 JP 2018065821A5 JP 2017218514 A JP2017218514 A JP 2017218514A JP 2017218514 A JP2017218514 A JP 2017218514A JP 2018065821 A5 JP2018065821 A5 JP 2018065821A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- seq
- antigens
- cationic lipid
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161533512P | 2011-09-12 | 2011-09-12 | |
| US61/533,512 | 2011-09-12 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014529976A Division JP6600459B2 (ja) | 2011-09-12 | 2012-09-12 | 粒子状ワクチン製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018065821A JP2018065821A (ja) | 2018-04-26 |
| JP2018065821A5 true JP2018065821A5 (https=) | 2018-06-28 |
Family
ID=47883670
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014529976A Active JP6600459B2 (ja) | 2011-09-12 | 2012-09-12 | 粒子状ワクチン製剤 |
| JP2017218514A Pending JP2018065821A (ja) | 2011-09-12 | 2017-11-13 | 粒子状ワクチン製剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014529976A Active JP6600459B2 (ja) | 2011-09-12 | 2012-09-12 | 粒子状ワクチン製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20150110823A1 (https=) |
| EP (1) | EP2755680B1 (https=) |
| JP (2) | JP6600459B2 (https=) |
| CN (2) | CN104066444A (https=) |
| ES (1) | ES2689799T3 (https=) |
| PL (1) | PL2755680T3 (https=) |
| TW (1) | TWI673062B (https=) |
| WO (1) | WO2013039989A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8877206B2 (en) | 2007-03-22 | 2014-11-04 | Pds Biotechnology Corporation | Stimulation of an immune response by cationic lipids |
| CA2721366C (en) | 2008-04-17 | 2017-06-06 | Elizabeth Ann Vasievich | Stimulation of an immune response by enantiomers of cationic lipids |
| CN104066444A (zh) * | 2011-09-12 | 2014-09-24 | Pds生物科技公司 | 微粒疫苗制剂 |
| CN105163753B (zh) | 2012-06-15 | 2018-12-21 | Pds生物科技公司 | 阳离子脂质疫苗组合物和使用方法 |
| CN105101991A (zh) | 2012-09-21 | 2015-11-25 | Pds生物科技公司 | 改进的疫苗组合物和使用方法 |
| WO2017083820A1 (en) | 2015-11-13 | 2017-05-18 | Pds Biotechnology Corporation | Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy |
| US20180221475A1 (en) * | 2016-10-05 | 2018-08-09 | Pds Biotechnology Corporation | Methods to alter the tumor microenvironment for effective cancer immunotherapy |
| SG11201902988UA (en) * | 2016-10-05 | 2019-05-30 | Pds Biotechnology Corp | Novel hpv16 non hla-restricted t-cell vaccines, compositions and methods of use thereof |
| CA3084957A1 (en) | 2017-12-05 | 2019-06-13 | Pds Biotechnology Corporation | Methods and compositions comprising cationic lipids for stimulating type 1 interferon genes |
| CA3126544A1 (en) * | 2019-01-12 | 2020-07-16 | The Methodist Hospital | Self-assembled peptide nanoparticle and use thereof |
| US20220409708A1 (en) * | 2019-11-01 | 2022-12-29 | Korea Advanced Institute Of Science And Technology | Small lipid nanoparticles, and cancer vaccine including same |
| WO2023145749A1 (ja) * | 2022-01-27 | 2023-08-03 | 一般財団法人阪大微生物病研究会 | 免疫賦活剤 |
| EP4511061A1 (en) | 2022-04-22 | 2025-02-26 | Universitat Autònoma de Barcelona | Immunogenic composition with protein micro- and nanoparticles |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6183745B1 (en) * | 1990-12-12 | 2001-02-06 | The University Of Queensland | Subunit papilloma virus vaccine and peptides for use therein |
| AUPM500494A0 (en) * | 1994-04-12 | 1994-05-05 | Minister For Agriculture & Rural Affairs For The State Of New South Wales, The | Composition for use in increasing mucosal immunity |
| AU6504596A (en) * | 1995-07-21 | 1997-02-18 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| FR2794370B1 (fr) * | 1999-06-03 | 2003-10-17 | Biovector Therapeutics | Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination |
| WO2002060412A2 (en) * | 2001-02-01 | 2002-08-08 | Board Of Regents | Stabilised polymeric aerosols for pulmonary gene delivery |
| US20050031587A1 (en) * | 2002-10-04 | 2005-02-10 | Yamanouchi Pharmaceutical Co., Ltd. | Immune response induction method |
| AU2004281634B2 (en) * | 2003-09-03 | 2011-01-27 | Dendritherapeutics, Inc. | Multiplex vaccines |
| CN1559607A (zh) * | 2004-02-20 | 2005-01-05 | �й�ũҵ��ѧ | 一种核酸物质与蛋白质类组合物及其生产方法和在免疫调节中的应用 |
| US7303881B2 (en) * | 2004-04-30 | 2007-12-04 | Pds Biotechnology Corporation | Antigen delivery compositions and methods of use |
| DE102004057303A1 (de) * | 2004-11-26 | 2006-06-01 | Merck Patent Gmbh | Stabile Kristallmodifikationen von DOTAP Chlorid |
| US20070059318A1 (en) * | 2005-08-15 | 2007-03-15 | Balu-Iyer Sathy V | Lipid nano particulates containing antigens as cancer vaccines |
| CA2630220C (en) * | 2005-11-22 | 2020-10-13 | Doris Coit | Norovirus and sapovirus antigens |
| JP2007238559A (ja) * | 2006-03-10 | 2007-09-20 | Nagoya City Univ | 未成熟樹状細胞活性化剤及びその使用 |
| US8877206B2 (en) * | 2007-03-22 | 2014-11-04 | Pds Biotechnology Corporation | Stimulation of an immune response by cationic lipids |
| CA2721366C (en) * | 2008-04-17 | 2017-06-06 | Elizabeth Ann Vasievich | Stimulation of an immune response by enantiomers of cationic lipids |
| WO2011109294A1 (en) * | 2010-03-01 | 2011-09-09 | Dicerna Pharmaceuticals, Inc. | Lipid delivery formulations |
| CN104066444A (zh) * | 2011-09-12 | 2014-09-24 | Pds生物科技公司 | 微粒疫苗制剂 |
-
2012
- 2012-09-12 CN CN201280055234.5A patent/CN104066444A/zh active Pending
- 2012-09-12 CN CN201910145079.XA patent/CN110075292A/zh active Pending
- 2012-09-12 PL PL12831495T patent/PL2755680T3/pl unknown
- 2012-09-12 ES ES12831495.2T patent/ES2689799T3/es active Active
- 2012-09-12 US US14/344,327 patent/US20150110823A1/en not_active Abandoned
- 2012-09-12 WO PCT/US2012/054786 patent/WO2013039989A1/en not_active Ceased
- 2012-09-12 EP EP12831495.2A patent/EP2755680B1/en active Active
- 2012-09-12 TW TW101133392A patent/TWI673062B/zh active
- 2012-09-12 JP JP2014529976A patent/JP6600459B2/ja active Active
-
2017
- 2017-11-13 JP JP2017218514A patent/JP2018065821A/ja active Pending
-
2019
- 2019-03-21 US US16/360,278 patent/US20190275145A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018065821A5 (https=) | ||
| Hess et al. | Phage display as a tool for vaccine and immunotherapy development | |
| Marasini et al. | Oral delivery of nanoparticle-based vaccines | |
| Ninomiya et al. | Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice | |
| JP5331340B2 (ja) | インフルエンザウィルスワクチン組成物、及びその使用方法 | |
| Kallerup et al. | Classification of vaccines | |
| JP2014522842A5 (https=) | ||
| JP2014520807A5 (https=) | ||
| Naskalska et al. | Virus like particles as immunogens and universal nanocarriers | |
| Tumban et al. | A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants | |
| JP7641005B2 (ja) | コンジュゲート型ウイルス様粒子および抗腫瘍免疫リダイレクタとしてのその使用 | |
| JP2017035093A5 (https=) | ||
| JP2018534304A5 (https=) | ||
| Li et al. | Bacteriophage T4 vaccine platform for next-generation influenza vaccine development | |
| TWI673062B (zh) | 粒狀疫苗調配物 | |
| EP4091630A1 (en) | Vaccines comprising r-dotap | |
| JP2016185988A5 (https=) | ||
| Even-Or et al. | Adjuvanted influenza vaccines | |
| JP2011504486A5 (https=) | ||
| Kianmehr et al. | Influence of Brucella abortus lipopolysaccharide as an adjuvant on the immunogenicity of HPV-16 L1VLP vaccine in mice | |
| JP2020526530A5 (https=) | ||
| JP2018514565A5 (https=) | ||
| Patel et al. | Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses | |
| JP2021521149A5 (https=) | ||
| Hendy et al. | Nano/microparticle Formulations for Universal Influenza Vaccines: Nano/microparticle Formulations for Universal Influenza Vaccines |